Clinical Trial Update: Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) [Phase 3]

View source ↗

Summary

Phase 3 trial update on bridging anticoagulation around surgery for atrial fibrillation; the study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thromboembolism
• Atrial Fibrillation

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• Heparin (unfractionated heparin)
• Warfarin (warfarin)

Snippet

Sponsor: Duke University | Conditions: Arterial Thromboembolic Events, Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2016-03-07